These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 31121559)

  • 1. Synthesis and in vitro anticancer evaluation of some fused indazoles, quinazolines and quinolines as potential EGFR inhibitors.
    Abdelsalam EA; Zaghary WA; Amin KM; Abou Taleb NA; Mekawey AAI; Eldehna WM; Abdel-Aziz HA; Hammad SF
    Bioorg Chem; 2019 Aug; 89():102985. PubMed ID: 31121559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel quinazolin-2-yl 1,2,3-triazole hybrids as promising multi-target anticancer agents: Design, synthesis, and molecular docking study.
    El Hamaky NFM; Hamdi A; Bayoumi WA; Elgazar AA; Nasr MNA
    Bioorg Chem; 2024 Jul; 148():107437. PubMed ID: 38749114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel 2-[thio]acetamide linked quinazoline/1,2,4-triazole/chalcone hybrids: Design, synthesis, and anticancer activity as EGFR inhibitors and apoptotic inducers.
    Abdelkhalek AS; Kothayer H; Soltan MK; Ibrahim SM; Elbaramawi SS
    Arch Pharm (Weinheim); 2024 Jul; 357(7):e2300627. PubMed ID: 38593298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Harnessing molecular hybridization approach to discover novel quinoline EGFR-TK inhibitors for cancer treatment.
    Ryad N; Elmaaty AA; M Ibrahim I; Ahmed Maghrabi AH; Yahya Alahdal MA; Saleem RM; Zaki I; Ghany LMAA
    Future Med Chem; 2024; 16(11):1087-1107. PubMed ID: 38722235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iodoquinazoline-derived VEGFR-2 and EGFR
    Mohamed AA; El-Hddad SSA; Aljohani AKB; Khedr F; Alatawi OM; Keshek DE; Ahmed S; Alsulaimany M; Almadani SA; El-Adl K; Hanafy NS
    Bioorg Chem; 2024 Feb; 143():107062. PubMed ID: 38150938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, biological assessment and molecular modeling studies of novel imidazothiazole-thiazolidinone hybrids as potential anticancer and anti-inflammatory agents.
    Kamboj P; Anjali ; Imtiyaz K; Rizvi MA; Nath V; Kumar V; Husain A; Amir M
    Sci Rep; 2024 Apr; 14(1):8457. PubMed ID: 38605072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compounds Consisting of Quinazoline, Ibuprofen, and Amino Acids with Cytotoxic and Anti-Inflammatory Effects.
    Garduño-Villavicencio LR; Martínez-Ortega U; Ortiz-Sánchez E; Tinajero-Rodríguez JM; Hernández-Luis F
    ChemMedChem; 2024 May; 19(10):e202300651. PubMed ID: 38354370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of novel ureido benzothiophenes as dual VEGFR-2/EGFR anticancer agents.
    Eldehna WM; Al-Ansary GH; Al-Warhi T; Jaballah MY; Elaasser M; Rashed M
    Bioorg Chem; 2024 Feb; 143():107037. PubMed ID: 38134521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis of benzimidazole tethered 3,4-dihydro-2H-benzo[e] [1, 3] oxazines as anticancer agents.
    Gali S; Raghu D; Mallikanti V; Thumma V; Vaddiraju N
    Mol Divers; 2024 Jun; 28(3):1347-1361. PubMed ID: 37233952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel 1,3,4-oxadiazole derivatives of naproxen targeting EGFR: Synthesis, molecular docking studies, and cytotoxic evaluation.
    Alsaad HN; Al-Jasani BM; Mahmood AAR; Tahtamouni LH; Saleh KM; AlSakhen MF; Kanaan SI; Yasin SR
    Drug Dev Res; 2024 Aug; 85(5):e22231. PubMed ID: 38956926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New Thiazolyl-Pyrazoline Derivatives as Potential Dual EGFR/HER2 Inhibitors: Design, Synthesis, Anticancer Activity Evaluation and In Silico Study.
    Fakhry MM; Mattar AA; Alsulaimany M; Al-Olayan EM; Al-Rashood ST; Abdel-Aziz HA
    Molecules; 2023 Nov; 28(21):. PubMed ID: 37959874
    [No Abstract]   [Full Text] [Related]  

  • 12. A series of quinazolin-4(3H)-one-morpholine hybrids as anti-lung-cancer agents: Synthesis, molecular docking, molecular dynamics, ADME prediction and biological activity studies.
    Tokalı FS; Şenol H; Ateşoğlu Ş; Akbaş F
    Chem Biol Drug Des; 2024 Jul; 104(1):e14599. PubMed ID: 39039616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of 2-Aryl Indazole: Synthesis, Biological Evaluationand In-Silico Studies.
    Krishna Atikala V; Akber Ansari S; Aamer Ansari I; Kapavarapu R; Babu Bollikolla H
    Chem Biodivers; 2024 Jul; 21(7):e202302085. PubMed ID: 38666662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of 1,5-diarylpyrazoles as EGFR/JNK-2 dual inhibitors: design, synthesis, moleecular docking, and bioactivity evaluation.
    Soltan OM; Abdel-Aziz SA; Sh Shaykoon M; Osawa K; Narumi A; Abdel-Aziz M; Shoman ME; Konno H
    Bioorg Med Chem Lett; 2024 Apr; 102():129673. PubMed ID: 38408511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of bis-thiohydantoin derivatives as an antiproliferative agents targeting EGFR inhibitory pathway.
    Hassan AA; Aly AA; Ramadan M; Mohamed NK; Youssif BGM; Gomaa HAM; Bräse S; Nieger M; El-Aal ASA
    Mol Divers; 2024 Jun; 28(3):1249-1260. PubMed ID: 37306891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis, in silico molecular docking, and ADMET studies of quinoxaline-isoxazole-piperazine conjugates as EGFR-targeting agents.
    Ali MI; Thirukovela NS; Kumar GB; Dasari G; Badithapuram V; Manchal R; Bandari S
    Chem Biol Drug Des; 2024 Mar; 103(3):e14499. PubMed ID: 38444047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and Characterization of a New Class of Chromene-Azo Sulfonamide Hybrids as Promising Anticancer Candidates with the Exploration of Their EGFR,
    Alblewi FF; Alsehli MH; Hritani ZM; Eskandrani A; Alsaedi WH; Alawad MO; Elhenawy AA; Ahmed HY; El-Gaby MSA; Afifi TH; Okasha RM
    Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis and anticancer activity evaluation of 4-(3-1H-indazolyl)amino quinazoline derivatives as PAK4 inhibitors.
    Han W; Yang Y; Yu F; Li Q; Liu A; Xu W; Li J; Xue X
    Bioorg Med Chem; 2023 Nov; 95():117501. PubMed ID: 37864885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemical Constituent Profiling of
    Abdelhameed RFA; Habib ES; Ibrahim AK; Yamada K; Abdel-Kader MS; Ahmed SA; Ibrahim AK; Badr JM; Nafie MS
    Molecules; 2021 Feb; 26(4):. PubMed ID: 33578916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel N-(3-ethynyl Phenyl)-6,7-bis(2-methoxyethoxy)Quinazoline-4-amine Derivatives: Synthesis, Characterization, Anti-cancer Activity,
    Dash A; Vaddamanu G; Karreddula R; Manubolu SSB; Kumari GP; Mulakayala N
    Anticancer Agents Med Chem; 2024; 24(7):514-532. PubMed ID: 38288814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.